Child proton pump inhibitor use may increase asthma risk

Child proton pump inhibitor use may increase asthma risk

Initiation of proton pump inhibitor (PPI) use is associated with an increased risk for asthma among children compared with nonuse, according to a study published online Feb. 8 in JAMA Pediatrics.

Yun-Han Wang, from the Karolinska Institutet in Stockholm, and colleagues examined the association between PPI use and risk for asthma in children in a nationwide cohort study. Data were included for 80,870 pairs of children and adolescents aged 17 years or younger matched by age and propensity scores.

The researchers found that the incidence rate of asthma was higher for those who initiated PPI use versus noninitiators (21.8 versus 14.0 events per 1,000 person-years), with a hazard ratio of 1.57. Across all , there was a significantly for asthma, with the highest risk observed for infants and toddlers (hazard ratios, 1.83 for those aged <6 months; 1.91 for those aged 6 months to <2 years). For individual PPIs, the hazard ratios were 1.64, 1.49, 1.43, and 2.33 for esomeprazole, lansoprazole, omeprazole, and pantoprazole, respectively. In analyses of the timing of asthma onset after PPI initiation, the hazard ratios were 1.62, 1.73, and 1.53 for 0 to 90 days, 91 to 180 days, and 181 days to end of follow-up, respectively. The association was consistent through sensitivity analyses.

"These findings suggest that is one of several potential adverse events that should be considered when prescribing PPIs to ," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.


Explore further

Asthma, uncontrolled asthma associated with risk of A-fib

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: JAMA Pediatrics

Copyright © 2020 HealthDay. All rights reserved.

Citation: Child proton pump inhibitor use may increase asthma risk (2021, February 9) retrieved 14 April 2021 from https://medicalxpress.com/news/2021-02-child-proton-inhibitor-asthma.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments